DNA repair inhibition by UVA photoactivated fluoroquinolones and vemurafenib

Cutaneous photosensitization is a common side effect of drug treatment and can be associated with an increased skin cancer risk. The immunosuppressant azathioprine, the fluoroquinolone antibiotics and vemurafenib—a BRAF inhibitor used to treat metastatic melanoma—are all recognized clinical photosen...

Descripción completa

Detalles Bibliográficos
Autores principales: Peacock, Matthew, Brem, Reto, Macpherson, Peter, Karran, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Genome Integrity, Repair and Replication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4267641/
https://www.ncbi.nlm.nih.gov/pubmed/25414333
http://dx.doi.org/10.1093/nar/gku1213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4267641/
https://www.ncbi.nlm.nih.gov/pubmed/25414333
http://dx.doi.org/10.1093/nar/gku1213

Ejemplares similares